Home›Search›Future Rare Diseases

Future Rare Diseases

Taylor and Francis Ltd. · United Kingdom · Est. 2020

ISSN2399-5270

SJR Q4✓ Scopus / SJR

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Norwegian Register Level 152

✓ Corroboration (1 more)+6

Total58

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

148

days submission → published

measured · last 20 articles · accept 110d

SJR Rank

Bottom 25%

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

SJR Scorei

0.15

H-Indexi

SNIPi

0.226

Total Worksi

137

Total Citationsi

161

2yr Mean Citednessi

0.17

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Future Rare Diseases is a peer-reviewed, open-access journal that publishes research on rare diseases, clinical disease management, diagnosis, genetic disorders, patient advocacy, and orphan drugs. It serves as a resource for scientists, clinicians, policy makers, and patient advocates to share knowledge and increase exposure for work in rare disease research and treatment development.

AI-compiled from public web sources · verify on the publisher page

General Information

Country / RegionUnited Kingdom

Primary Language—

1st Year Published2020

Annual Volume~ 32 articles / year

StatusActive (last: 2026)

Total Publications137

Publisher OrgFuture Medicine

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/12 · 33%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

2399-5270

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q4

Subject Classification

Scopus Categories

Medicine (miscellaneous)

Research Topics (OpenAlex)

Lysosomal Storage Disorders ResearchGenomics and Rare DiseasesRenal Diseases and GlomerulopathiesGenetics and Neurodevelopmental DisordersFamily and Disability Support ResearchInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisHemophilia Treatment and ResearchAutism Spectrum Disorder ResearchComplement system in diseasesBlood groups and transfusion

Frequently asked questions about Future Rare Diseases

Is Future Rare Diseases a predatory journal?

PubScope has no integrity flags on record for Future Rare Diseases: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 58/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Future Rare Diseases?

Future Rare Diseases is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.15.

Is Future Rare Diseases indexed in Scopus and Web of Science?

Future Rare Diseases is indexed in Scopus.